Advanced, Androgen Receptor Positive Triple Negative Breast Cancer
1 clinical trials · Condition
◉ Watch Advanced, Androgen Receptor Positive Triple Negative Breast Cancer
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast Cancer (NCT01889238) | Pfizer | 2013-06-12 |
Track Advanced, Androgen Receptor Positive Triple Negative Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.